Outcomes Using MARS for Patients With ALF

Completed

Conditions studied: Alcoholic Hepatitis, Acute Liver Failure

In brief

Retrospective chart review will be conducted on patients at Methodist Dallas Medical Center, meeting the inclusion criteria from January 1, 2019 to December 15, 2020 to determine the transplant free survival and overall survival and other secondary outcome measures.

Key facts

Study ID

NCT05594953

Run by

Methodist Health System

People needed

27

Starts

2021-04-23

Expected to finish

2026-05-12

Last updated by the study team

2026-06-11

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• The patient was diagnosed with: Alcoholic hepatitis; AoCLF; OR Acute fulminant liver failure
• The patient underwent at least one round of dialysis using plasma exchange or MARSTM

You may not qualify if…

• Patient not meeting the inclusion criteria will be excluded.
• All patients who underwent MARS at MDMC will be included in the study population.

Where it is running

• Methodist Dallas Medical Center — Dallas, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.